BR0317612A - Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene - Google Patents

Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene

Info

Publication number
BR0317612A
BR0317612A BR0317612-6A BR0317612A BR0317612A BR 0317612 A BR0317612 A BR 0317612A BR 0317612 A BR0317612 A BR 0317612A BR 0317612 A BR0317612 A BR 0317612A
Authority
BR
Brazil
Prior art keywords
infectious disease
inflammatory conditions
characterization
identification
monitoring
Prior art date
Application number
BR0317612-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael C Bevilacqua
Victor Tryon
Danute M Bankaitis-Davis
John C Cheronis
Original Assignee
Source Precision Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Source Precision Medicine Inc filed Critical Source Precision Medicine Inc
Publication of BR0317612A publication Critical patent/BR0317612A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR0317612-6A 2002-12-19 2003-12-19 Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene BR0317612A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43525702P 2002-12-19 2002-12-19
PCT/US2003/040551 WO2004057034A1 (en) 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles

Publications (1)

Publication Number Publication Date
BR0317612A true BR0317612A (pt) 2005-12-06

Family

ID=32682206

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317612-6A BR0317612A (pt) 2002-12-19 2003-12-19 Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene

Country Status (8)

Country Link
EP (1) EP1579008A1 (enExample)
JP (2) JP2006510382A (enExample)
CN (1) CN1751129B (enExample)
AU (1) AU2003303238B2 (enExample)
BR (1) BR0317612A (enExample)
CA (1) CA2511237A1 (enExample)
MX (1) MXPA05006804A (enExample)
WO (1) WO2004057034A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505921A1 (en) 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
EP2128270B1 (en) 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
AU2006294477A1 (en) * 2005-09-27 2007-04-05 Source Mdx Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
CA2652239A1 (en) * 2006-05-16 2007-11-29 Source Mdx Assessment of effect of an agent on a human biological condition using rodent gene expression panels
WO2008048986A2 (en) * 2006-10-17 2008-04-24 Children's Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
DE102007036678B4 (de) * 2007-08-03 2015-05-21 Sirs-Lab Gmbh Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion
TWI600759B (zh) 2010-04-02 2017-10-01 可娜公司 藉由抑制群落刺激因子3(csf3)之天然反義轉錄物以治療csf3相關疾病
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
BR112017019373A2 (pt) * 2015-03-12 2018-06-05 Koninklijke Philips N.V. método implementado por computador, e, mídia legível por computador
US11031119B2 (en) * 2019-11-13 2021-06-08 Cube Click, Inc. Dental images processed with deep learning for national security
CN118824376B (zh) * 2024-09-18 2025-01-21 江苏省疾病预防控制中心(江苏省预防医学科学院) 基于元学习技术的呼吸系统传染病人工智能辅助筛查系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960214A4 (en) * 1996-12-06 2004-08-04 Urocor Inc Diagnosis of disease status on HAnd from mRNA profiles
DK1198585T3 (da) * 1999-06-28 2007-10-15 Source Precision Medicine Inc Fremgangsmåde til karakterisering af en biologisk tilstand ved anvendelse af kalibrerede genudtrykkelsesprofiler
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

Also Published As

Publication number Publication date
AU2003303238B2 (en) 2010-07-22
CN1751129A (zh) 2006-03-22
JP2010227111A (ja) 2010-10-14
EP1579008A1 (en) 2005-09-28
WO2004057034A1 (en) 2004-07-08
CN1751129B (zh) 2014-07-23
AU2003303238A1 (en) 2004-07-14
JP2006510382A (ja) 2006-03-30
MXPA05006804A (es) 2006-03-30
CA2511237A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
WO2007038754A3 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
WO2008069881A3 (en) Gene expression profiling for identification, monitoring and treatment of melanoma
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
BR0317612A (pt) Identificação, monitoração e tratamento de doença infecciosa e caracterização de condições inflamatórias relacionadas com doença infecciosa empregando perfis de expressão de gene
BRPI0412184A (pt) renderização de anúncios com documentos tendo um ou mais tópicos utilizando informação de interesse de tópico do usuário
CY1107733T1 (el) Μεθοδος για τον χαρακτηρισμο μιας βιολογικης καταστασης χρησιμοποιωντας βαθμοnομημενα προφιλ γονιδιακης εκφρασης
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
ITTO20010411A0 (it) Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti.
EP2333541A3 (en) Methods and Materials for Canine Breed Identification
BR0314019A (pt) Métodos de detectar, caracterizar ou monitorar uma zona de hidrocarboneto, uso de uma ou mais sondas de oligonucleotìdeo, bateria de sondas, oligonucleotìdeo, suporte sólido, e, kit para uso no método
ATE530635T1 (de) Verfahren und quantifizierungsassay zur bestimmung des c-kit/scf/pakt-status
BR0010068A (pt) Sistema de identificação do marcador fenotìpico e biológico
WO2005042761A3 (en) Biomarkers for amyotrophic lateral sclerosis
DE60140120D1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
DE60328069D1 (de) Test-Photomaske, Streulichtbewertungsverfahren, und Streulichtkompensierungsverfahren
WO2003048300A3 (en) Methods of identifying cellular target molecules
EP1415152A4 (en) METHOD, DEVICES AND COMPUTER PROGRAMS FOR VERIFYING THE INTEGRITY OF A PROBE
WO2005086679A3 (en) Methods and compositions for assessing nucleic acids and alleles
BRPI0608079A2 (pt) avaliação do tono simpático
WO2002012892A3 (en) Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
WO2004094992A3 (en) Methods for analysis of biological dataset profiles
BRPI0515325A (pt) processo para simular os efeitos corrosivos dos estoques de provisão de refinaria sobre a metalurgia de refinaria
BR0102781A (pt) Processos para identificação de combinações de entidades como terapêuticos
DE60334923D1 (de) Tät

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2285 DE 21/10/2014.